A Case of Corneal Melting in a Patient with HER2-Positive Breast Cancer

Trastuzumab is the cornerstone treatment for HER2-positive breast cancer. While ocular side effects are more commonly described after the use of the antibody-drug conjugate ado-trastuzumab emtansine, we here describe corneal melting in a 79-year-old patient after three cycles of trastuzumab monother...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeters, Deborah, Vereecken, Melissa, Denys, Hannelore, Roels, Dimitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808133/
https://www.ncbi.nlm.nih.gov/pubmed/36605044
http://dx.doi.org/10.1159/000527236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808133/
https://www.ncbi.nlm.nih.gov/pubmed/36605044
http://dx.doi.org/10.1159/000527236

Ejemplares similares